arrow
M

Margaret Haworth-Brockman

University of Manitoba
H指数:13
被引数:649

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Perspectives from the Canadian public health community on the use, adoption barriers to, and implementation supports needed for the Core Competencies for Public Health in Canada: Release 2.0

加拿大公共卫生界对《加拿大公共卫生核心能力:2.0版》的使用、采纳障碍及实施支持需求的观点

2026-10-210
OAAI
Increasing rates of Chlamydia trachomatis infection in Alberta, Saskatchewan, and Manitoba compared to Canada overall, between 1991 and 2022

与加拿大整体情况相比,1991年至2022年间阿尔伯塔省、萨斯喀彻温省和曼尼托巴省沙眼衣原体感染率的上升幅度。

2026-03-140
OAAI
Epidemiology of hepatitis C in Alberta, Saskatchewan, and Manitoba compared to Canada, 1980-2023

1980-2023年阿尔伯塔省、萨斯喀彻温省和曼尼托巴省与加拿大丙型肝炎流行病学比较

2026-01-010
OAAI
Barriers and recommendations for harm reduction services among people living with HIV in Manitoba; Canada: a qualitative study

加拿大马尼托巴省艾滋病病毒感染者中伤害减少服务的障碍与建议:一项定性研究

2025-09-270
OAAI
Mycoplasma genitalium Infections and Associated Antimicrobial Resistance in Canada, 1980-2023

Mycoplasma genitalium感染及其在加拿大的抗菌药物耐药性,1980-2023

2025-05-190
OA
Our needs, our priorities, listen to us! recommendations for improving HIV prevention and the cascade of care from people living with HIV in Manitoba, Canada: a qualitative study

我们的需求、我们的优先事项,倾听我们!来自加拿大马尼托巴省艾滋病病毒感染者关于改善艾滋病预防及照护连续性的建议:一项定性研究

2025-04-230
OA
Do COVID-19 Infectious Disease Models Incorporate the Social Determinants of Health? A Systematic Review

新型冠状病毒肺炎传染病模型是否包含健康的社会决定因素?一项系统综述

2024-10-100
OAAI
One Health Evaluation of Antimicrobial Use and Resistance Surveillance: A Novel Tool for Evaluating Integrated, One Health Antimicrobial Resistance and Antimicrobial Use Surveillance Programs

抗菌药物使用和耐药性监测的一项健康评估: 一种用于评估综合,一项健康的抗菌药物耐药性和抗菌药物使用监测计划的新工具

2021-08-048
OAAI